The purpose of this analysis is to make available to readers a series of data relating to 5 of the most important companies that release the earnings reports during the week.
In particular, the data concern analysts ‘expectations about growth in EPS and Revenue, transactions in the last quarter by Hedge Funds and Insiders, analysts’ target price and a risk indicator.
The information mentioned above is contained within a “card”. In addition, you can find a stock price graph to compare it with the S&P 500 index (black line).
Information contained in the “card”:
- “Estimated EPS / Revenue Growth Y-o-Y”: growth or decrease expected by analysts on Earnings-Per-Share (EPS) and Revenue in this quarter compared to the same quarter of 12 months before
- “Hedge Funds Buy / Sell”: indicates the number of shares purchased (if the box is green) or sold (if the box is red) by Hedge Funds in the last quarter
- “Insiders Buy / Sell”: the total value of the shares bought (if the box is green) or sold (if the box is red) by the Insiders in the last quarter
- “Target Price”: the potential Upside (if the box is green) or Downside (if the box is red and with a negative sign) of the stock price in the following 12 months according to analysts
- “Beta”: coefficent that measures the volatility of a stock’s returns relative to the market (S&P 500 index) in the last 60 months. The stock will be more risky than the market based on how much the beta is above 1
The information contained within the “cards” is for informational purposes only. Volatility during this event is high and the risks are high. Trade responsibly.
JPMorgan Chase & Co. (JPM)
JPMorgan Chase & Co. operates as a financial services company worldwide. It operates in four segments: Consumer & Community Banking (CCB), Corporate & Investment Bank (CIB), Commercial Banking (CB), and Asset & Wealth Management (AWM).
JPM releases the quarterly report on 04/14/20 .
Analysts in this quarter expect -17,70% EPS decrease and 4,20% Revenue growth .
In the last quarter Hedge Funds have decreased their positions by 11.3M shares, while the Insiders bought shares for $7.09M .
Analysts believe JPM is undervalued by 12,74% at current prices.
Johnson & Johnson (JNJ)
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the health care field worldwide. It operates in three segments: Consumer, Pharmaceutical, and Medical Devices.
JNJ releases the quarterly report on 04/14/20 .
Analysts in this quarter expect -5,20% EPS decrease and -3,10% Revenue decrease .
In the last quarter Hedge Funds have decreased their positions by 170.6k shares, while the Insiders sold shares for $8.62M .
Analysts believe JNJ is undervalued by 10,38% at current prices.
UnitedHealth Group Incorporated (UNH)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx.
UNH releases the quarterly report on 04/15/20 .
Analysts in this quarter expect -2,70% EPS decrease and 6,70% Revenue growth .
In the last quarter Hedge Funds have increased their positions by 3.6M shares, while the Insiders sold shares for $15.6M .
Analysts believe UNH is undervalued by 21,78% at current prices.
Bank of America Corporation (BAC)
Bank of America Corporation, through its subsidiaries, provides banking and financial products and services for individual consumers, small- and middle-market businesses, institutional investors, large corporations, and governments worldwide.
BAC releases the quarterly report on 04/15/20 .
Analysts in this quarter expect -31,40% EPS decrease and -1,70% Revenue decrease .
In the last quarter Hedge Funds have decreased their positions by 9.7M shares.
Analysts believe BAC is undervalued by 15,12% at current prices.
Abbott Laboratories (ABT)
Abbott Laboratories discovers, develops, manufactures, and sells health care products worldwide.
ABT releases the quarterly report on 04/16/20 .
Analysts in this quarter expect -1,60% EPS decrease and 1,20% Revenue growth .
In the last quarter Hedge Funds have decreased their positions by 1.7M shares, while the Insiders sold shares for $2.02M .
Analysts believe ABT is undervalued by 12,39% at current prices.
Want to know what other types of analysis are available on BullDude.com?
Click here to find out !!!
This analysis provides you useful information on the best companies that will release the earnings reports soon.
If you are interested in statistical analysis before the publication of the earnings reports, an analysis of the quarterly report results released or an analysis of the top 20 companies that release the earnings report during the week, I am waiting for you here.
Alternatively, If you are interested in a overall analysis of companies taking into account different types of data (including business growth, analysts expectations and transactions made by Hedge Funds / Insiders), summarizing all this information in a simple score, I am waiting for you here for my Score-Card analysis.
Do you want to stay updated on all the analysis published?Follow @BulldudeC
Sources & additional info
*Information on target prices, Insiders and Hedge Funds by tipranks.com
*Information on EPS and Revenues estimated by finance.yahoo.com
*The other earnings reports “card” information from barchart.com
*Charts by Tradingview.com
DISCLAIMER: The information in this blog post represents my own analysis/opinions and does not contain a recommendation for any particular security or investment. Stocks trading involves substantial risk of loss and is not suitable for every investor. Trade responsibly.